Latest Breaking News On - Card fail - Page 1 : comparemela.com

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms

United statesCanwen jiangChristian rommelCenters for diseaseDrug administrationAsklepios biopharmaceutical incBayer agAmerican heart associationHead of researchFast track programBayer pharmaceuticals divisionGlobal public health burden of heart failureAsklepios biopharmaceuticalFast track designationTrack designationChief development officer

First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure

First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomNorth carolinaUnited statesPais vascoUniversity of north carolinaCity ofResearch triangle parkR jude samulskiRogerj hajjarChristian rommelPhil mcnamaraJosh griegerTimothyd henryHead of researchSpanish agency for medicinesAsklepios biopharmaceutical inc

First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms1GenePHIT is a clinical trial to evaluate the safety and efficacy of the one-time administration of AB-1002 and will include the largest number.

University of north carolinaNorth carolinaUnited statesResearch triangle parkCity ofUnited kingdomPais vascoRogerj hajjarJosh griegerPhil mcnamaraR jude samulskiChristian rommelTimothyd henrySteering committee memberTrademark officeManufacturing organization

First Patient Randomized In Askbio Phase II Gene Therapy Trial For Congestive Heart Failure

First Patient Randomized In Askbio Phase II Gene Therapy Trial For Congestive Heart Failure
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

University of north carolinaNorth carolinaUnited statesPais vascoResearch triangle parkUnited kingdomCity ofChristian rommelAnn pentecost bayerTimothyd henryR jude samulskiRogerj hajjarJosh griegerPhil mcnamara askbioSpanish agency for medicinesTechnology park

AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)

GenePHIT, which is now enrolling, will study AB-1002 in adults with NYHA Class III Heart Failure and non-ischemic cardiomyopathy

United statesJude samulskiRoger hajjarLothar roessigAsklepios biopharmaceutical incAmerican heart associationCenters for diseaseProduct team leadGlobal public health burden of heart failureYork heart associationBayer agAsklepios biopharmaceuticalInhibition therapyNew york heart associationScientific chairIntegrated product team lead